COMPANY
Clinical Phase 1
Location: San Diego, CA · source · Oct 13, 2026
Profile checked Oct 10, 2026
Keywords: Esophageal Squamous Cell Carcinoma Gastric Adenocarcinoma Gastric Squamous Cell Carcinoma Gastroesophageal Junction (GEJ) Adenocarcinoma Non-Small Cell Lung Carcinoma Esophageal Adenocarcinoma SMARCA4 Mutation Gastroesophageal Junction Squamous Cell Carcinoma PLX-61639
Timeline
- Trial start Phase 1: First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors source ↗
Upcoming milestones
- 2029-12 (ESTIMATED) · Phase 1 · First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors · NCT07284186
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT07284186 | First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors | Phase 1 | Recruiting | Dec 1, 2025 | 2029-12 (estimated) |
